These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23713859)

  • 41. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.
    Nakamura K; Sakaguchi M; Matsubara H; Akagi S; Sarashina T; Ejiri K; Akazawa K; Kondo M; Nakagawa K; Yoshida M; Miyoshi T; Ogo T; Oto T; Toyooka S; Higashimoto Y; Fukami K; Ito H
    PLoS One; 2018; 13(9):e0203046. PubMed ID: 30180189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-27a/b mediates endothelin-1-induced PPARγ reduction and proliferation of pulmonary artery smooth muscle cells.
    Xie X; Li S; Zhu Y; Liu L; Pan Y; Wang J; Shi W; Song Y; Yang L; Gao L; Zang W; Li M
    Cell Tissue Res; 2017 Sep; 369(3):527-539. PubMed ID: 28484848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension.
    Liu H; Yin T; Yan W; Si R; Wang B; Chen M; Li F; Wang Q; Tao L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1781-1791. PubMed ID: 28684904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory Antibodies against Activin A and TGF-β Reduce Self-Supported, but Not Soluble Factors-Induced Growth of Human Pulmonary Arterial Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension.
    Kudryashova TV; Shen Y; Pena A; Cronin E; Okorie E; Goncharov DA; Goncharova EA
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
    Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
    J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-190 regulates hypoxic pulmonary vasoconstriction by targeting a voltage-gated K⁺ channel in arterial smooth muscle cells.
    Li SS; Ran YJ; Zhang DD; Li SZ; Zhu D
    J Cell Biochem; 2014 Jun; 115(6):1196-205. PubMed ID: 24446351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells.
    Zeng Y; Liu H; Kang K; Wang Z; Hui G; Zhang X; Zhong J; Peng W; Ramchandran R; Raj JU; Gou D
    Sci Rep; 2015 Jul; 5():12098. PubMed ID: 26166214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noncoding RNAs in Pulmonary Arterial Hypertension: Current Knowledge and Translational Perspectives.
    Bernardi N; Bianconi E; Vecchi A; Ameri P
    Heart Fail Clin; 2023 Jan; 19(1):137-152. PubMed ID: 36435569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension.
    Satoh K; Kikuchi N; Satoh T; Kurosawa R; Sunamura S; Siddique MAH; Omura J; Yaoita N; Shimokawa H
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulation of microRNA-17-5p contributes to hypoxia-induced proliferation in human pulmonary artery smooth muscle cells through modulation of p21 and PTEN.
    Liu G; Hao P; Xu J; Wang L; Wang Y; Han R; Ying M; Sui S; Liu J; Li X
    Respir Res; 2018 Oct; 19(1):200. PubMed ID: 30305109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
    Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S
    Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of mitochondrial fission prevents hypoxia-induced metabolic shift and cellular proliferation of pulmonary arterial smooth muscle cells.
    Parra V; Bravo-Sagua R; Norambuena-Soto I; Hernández-Fuentes CP; Gómez-Contreras AG; Verdejo HE; Mellado R; Chiong M; Lavandero S; Castro PF
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2891-2903. PubMed ID: 28739174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership.
    Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX
    Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Requirement of miR-9-dependent regulation of Myocd in PASMCs phenotypic modulation and proliferation induced by hepatopulmonary syndrome rat serum.
    Xu D; Gu JT; Yi B; Chen L; Wang GS; Qian GS; Lu KZ
    J Cell Mol Med; 2015 Oct; 19(10):2453-61. PubMed ID: 26147104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension.
    Li Y; Ren W; Wang X; Yu X; Cui L; Li X; Zhang X; Shi B
    Biomed Pharmacother; 2019 Jan; 109():1740-1749. PubMed ID: 30551428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension.
    Kim JD; Lee A; Choi J; Park Y; Kang H; Chang W; Lee MS; Kim J
    Exp Mol Med; 2015 Jul; 47(7):e175. PubMed ID: 26228095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.